Virginia Sedeño-Monge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Virginia Sedeño-Monge has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Gerardo Santos-López
Instituto Mexicano del Seguro Social
3 shared publications - Adriana Hernández Reyes
Facultad de Biotecnología, Universidad Popular Autónoma del Estado de Puebla, México
1 shared publication Adriana Oliveros-Montiel
Universidad Popular Autónoma del Estado de Puebla, Health Sciences Deanship, Faculty of Medicine, Puebla, Mexico
1 shared publicationAnia Villavicencio Flores
Deanery of Medical Sciences, Faculty of Medicine, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
1 shared publicationAnnia Rodríguez Rivera
Facultad de Biotecnología, Universidad Popular Autónoma del Estado de Puebla, México
1 shared publication- Carolina Jasso-Miranda
Departamento de Ciencias Químico-Biológicas y Agropecuarias, Universidad de Sonora, Caborca 83621, Mexico
1 shared publication
Latest Publications
- 27 May 2026
- Published by Elsevier in Human Immunology
- Vol. 87 (7) , 111763
Reduced socs2 expression and elevated IL-4/IL-23 levels in multiple sclerosis patients: Implications for immune dysregulation
- 27 May 2026
- Published by Elsevier in Human Immunology
- Vol. 87 (7) , 111763
Reduced socs2 expression and elevated IL-4/IL-23 levels in multiple sclerosis patients: Implications for immune dysregulation
- Open Access
- 6 March 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e945578
Hypothyroidism and Double Mitral Lesion in Antiphospholipid Syndrome During Pregnancy: A Case Report
Rare coexistence of disease or pathology Antiphospholipid syndrome (APS) is an immune system disorder that causes an increased risk of blood clots and has been associated with the development of hypothyroidism and double mitral lesion, possibly due to immune complex deposition. This report describes a 34-year-old woman presenting with hypothyroidism and antiphospholipid syndrome with a double mitral lesion at 26 weeks of gestation. We report the case of a 34-year-old woman with a history of hyperthyroidism that evolved into primary hypothyroidism, as well as APS under medical treatment, and fetal death during her first pregnancy. Subsequently, at 26 weeks of gestation in her second pregnancy, she presented a clinical picture of respiratory failure and precordial pain, which persisted with the same intensity and location despite postural changes for 2 days; after that, she had an increase in chest pain with irradiation to the front part of the chest, progressing to orthopnea. She was evaluated in the emergency room by Cardiology, where an echocardiogram was performed, which showed a double mitral lesion. The decision was made to admit her to intensive care with this diagnosis and pulmonary edema and establishing the specific treatment. She remained under obstetric surveillance and cardiovascular treatment until she was discharged. She maintained maternal-fetal stability cardiologic and endocrinological care, allowing the pregnancy to be successfully carried out to term without complications, and she and her baby showed very good perinatal results during the postpartum period. This report highlights the importance of timely and accurate diagnosis of antiphospholipid syndrome and highlights the association with both hypothyroidism and double mitral lesion.
- 6 March 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e945578
Open AccessHypothyroidism and Double Mitral Lesion in Antiphospholipid Syndrome During Pregnancy: A Case Report
Rare coexistence of disease or pathology Antiphospholipid syndrome (APS) is an immune system disorder that causes an increased risk of blood clots and has been associated with the development of hypothyroidism and double mitral lesion, possibly due to immune complex deposition. This report describes a 34-year-old woman presenting with hypothyroidism and antiphospholipid syndrome with a double mitral lesion at 26 weeks of gestation. We report the case of a 34-year-old woman with a history of hyperthyroidism that evolved into primary hypothyroidism, as well as APS under medical treatment, and fetal death during her first pregnancy. Subsequently, at 26 weeks of gestation in her second pregnancy, she presented a clinical picture of respiratory failure and precordial pain, which persisted with the same intensity and location despite postural changes for 2 days; after that, she had an increase in chest pain with irradiation to the front part of the chest, progressing to orthopnea. She was evaluated in the emergency room by Cardiology, where an echocardiogram was performed, which showed a double mitral lesion. The decision was made to admit her to intensive care with this diagnosis and pulmonary edema and establishing the specific treatment. She remained under obstetric surveillance and cardiovascular treatment until she was discharged. She maintained maternal-fetal stability cardiologic and endocrinological care, allowing the pregnancy to be successfully carried out to term without complications, and she and her baby showed very good perinatal results during the postpartum period. This report highlights the importance of timely and accurate diagnosis of antiphospholipid syndrome and highlights the association with both hypothyroidism and double mitral lesion.
- Open Access
- 19 June 2024
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 92 (2) , 33
Non-Analog Compounds to Sialic Acid as Inhibitors of Influenza Virus Neuraminidase: An Underexplored Approach for Novel Antivirals―Systematic Review
Influenza poses a significant threat to public health worldwide, particularly among vulnerable populations such as children, the elderly, immunocompromised individuals, and those with chronic diseases. It is associated with high mortality and morbidity rates. Neuraminidase inhibitors play a crucial role in influenza treatment by mitigating the risk of complications and death. However, the genetic variability of the influenza virus enables the emergence of drug-resistant mutations. This review focuses on the search for new compounds that are not analogous to sialic acid, aiming to inhibit the activity of viral neuraminidase in vitro, viral replication in cell cultures, or animal models. Influenza virus strains that have been reported in the literature present specific mutations that generate resistance to neuraminidase inhibitors. Since these inhibitors bear structural resemblance to sialic acid, the predominant location for these mutations is the enzyme’s active site. Consequently, exploring alternative compound classes becomes imperative to circumvent this interaction pattern. These compounds will introduce diverse molecular frameworks, serving as foundational structures for further development through rational drug design, thereby engendering novel antiviral agents targeting influenza. The potential prospects for developing novel influenza antivirals based on these findings are discussed.
- 19 June 2024
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 92 (2) , 33
Open AccessNon-Analog Compounds to Sialic Acid as Inhibitors of Influenza Virus Neuraminidase: An Underexplored Approach for Novel Antivirals―Systematic Review
Influenza poses a significant threat to public health worldwide, particularly among vulnerable populations such as children, the elderly, immunocompromised individuals, and those with chronic diseases. It is associated with high mortality and morbidity rates. Neuraminidase inhibitors play a crucial role in influenza treatment by mitigating the risk of complications and death. However, the genetic variability of the influenza virus enables the emergence of drug-resistant mutations. This review focuses on the search for new compounds that are not analogous to sialic acid, aiming to inhibit the activity of viral neuraminidase in vitro, viral replication in cell cultures, or animal models. Influenza virus strains that have been reported in the literature present specific mutations that generate resistance to neuraminidase inhibitors. Since these inhibitors bear structural resemblance to sialic acid, the predominant location for these mutations is the enzyme’s active site. Consequently, exploring alternative compound classes becomes imperative to circumvent this interaction pattern. These compounds will introduce diverse molecular frameworks, serving as foundational structures for further development through rational drug design, thereby engendering novel antiviral agents targeting influenza. The potential prospects for developing novel influenza antivirals based on these findings are discussed.
- 1 March 2020
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 156 (2) , 156-163
Complications in pregnancies achieved by assisted reproduction
Introduction: Pregnancies resulting from assisted reproductive technologies (ART) have been documented to have a higher risk of adverse effects. Objective: To provide evidence on obstetric and perinatal complications associated with conceptions by ART versus spontaneous pregnancies. Method: Comprehensive review of original articles published between 2010 and 2018 addressing the more common obstetric and perinatal complications in pregnancies resulting from in vitro fertilization (OVF) and intracytoplasmic sperm injection (ICSI), in comparison with spontaneous conceptions. Results: Thirty-seven original articles, which reported on 26 cohort studies and 11 case-control trials, were included. IVF and ICSI conceptions were associated with a larger number of obstetric and perinatal complications such as low birth weight, prematurity, low weight for gestational age, admission to the neonatal intensive care unit, congenital malformations, C-sectionand premature rupture of membranes, among others. Conclusions: Pregnancies by ART are associated with an increased risk of obstetric and perinatal complications in comparison with spontaneous conceptions. Further research is needed to determine which aspects result in higher risk.
- 1 March 2020
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 156 (2) , 156-163
Complications in pregnancies achieved by assisted reproduction
Introduction: Pregnancies resulting from assisted reproductive technologies (ART) have been documented to have a higher risk of adverse effects. Objective: To provide evidence on obstetric and perinatal complications associated with conceptions by ART versus spontaneous pregnancies. Method: Comprehensive review of original articles published between 2010 and 2018 addressing the more common obstetric and perinatal complications in pregnancies resulting from in vitro fertilization (OVF) and intracytoplasmic sperm injection (ICSI), in comparison with spontaneous conceptions. Results: Thirty-seven original articles, which reported on 26 cohort studies and 11 case-control trials, were included. IVF and ICSI conceptions were associated with a larger number of obstetric and perinatal complications such as low birth weight, prematurity, low weight for gestational age, admission to the neonatal intensive care unit, congenital malformations, C-sectionand premature rupture of membranes, among others. Conclusions: Pregnancies by ART are associated with an increased risk of obstetric and perinatal complications in comparison with spontaneous conceptions. Further research is needed to determine which aspects result in higher risk.
- 2 June 2014
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 273 (1-2) , 117-119
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis
- 2 June 2014
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 273 (1-2) , 117-119
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis